Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Prostate Cancer

  Free Subscription


26.03.2018

3 BJU Int
1 Br J Cancer
1 Clin Cancer Res
1 Eur Urol
1 Hum Pathol
3 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Magn Reson Imaging
2 J Natl Cancer Inst
1 J Urol
1 Lancet Oncol
1 N Engl J Med
2 Nat Rev Urol
1 Oncogene
1 Oncology (Williston Park)
1 Prog Urol
1 Radiology
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BJU Int

  1. SU J, Zhu Q, Yuan L, Zhang Y, et al
    Transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study.
    BJU Int. 2018;121:111-118.
    PubMed     Text format     Abstract available

  2. SHIN T, Smyth TB, Ukimura O, Ahmadi N, et al
    Diagnostic accuracy of a five-point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image-fusion targeted biopsy of the prostate.
    BJU Int. 2018;121:77-83.
    PubMed     Text format     Abstract available

  3. BORKOWETZ A, Hadaschik B, Platzek I, Toma M, et al
    Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naive patients.
    BJU Int. 2018;121:53-60.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. MURTOLA TJ, Vihervuori VJ, Lahtela J, Talala K, et al
    Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Br J Cancer. 2018 Mar 22. pii: 10.1038/s41416-018-0055.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. WELTI J, Sharp A, Yuan W, Dolling DI, et al
    Targeting bromodomain and extra-terminal (BET) family proteins in castration resistant prostate cancer (CRPC).
    Clin Cancer Res. 2018 Mar 19. pii: 1078-0432.CCR-17-3571.
    PubMed     Text format     Abstract available


    Eur Urol

  6. HAO J, Ci X, Xue H, Wu R, et al
    Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Eur Urol. 2018 Mar 12. pii: S0302-2838(18)30162.
    PubMed     Text format     Abstract available


    Hum Pathol

  7. GORDETSKY JB, Schultz L, Porter KK, Nix JW, et al
    Defining the Optimal Method for Reporting Prostate Cancer Grade and Tumor Extent on MR/US Fusion Targeted Biopsies.
    Hum Pathol. 2018 Mar 15. pii: S0046-8177(18)30082.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  8. CYSOUW M, Bouman-Wammes E, Hoekstra O, van den Eertwegh A, et al
    Prognostic Value of [(18)F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30252.
    PubMed     Text format     Abstract available

  9. TANDBERG DJ, Oyekunle T, Lee WR, Wu Y, et al
    Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens.
    Int J Radiat Oncol Biol Phys. 2018 Feb 8. pii: S0360-3016(18)30248.
    PubMed     Text format     Abstract available

  10. WILKINS AC, Gusterson B, Szijgyarto Z, Haviland J, et al
    Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Feb 3. pii: S0360-3016(18)30186.
    PubMed     Text format     Abstract available


    J Clin Oncol

  11. PAN HY, Jiang J, Hoffman KE, Tang C, et al
    Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.
    J Clin Oncol. 2018 Mar 21:JCO2017755371. doi: 10.1200/JCO.2017.75.5371.
    PubMed     Text format     Abstract available


    J Magn Reson Imaging

  12. LIM CS, McInnes MD, Lim RS, Breau RH, et al
    Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy.
    J Magn Reson Imaging. 2016 Nov 3. doi: 10.1002/jmri.25539.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  13. THOMPSON I JR., Goodman P, Tangen C
    Reduced Risk of Prostate Cancer With 5alpha-Reductase Inhibitors.
    J Natl Cancer Inst. 2018 Mar 14. pii: 4935098. doi: 10.1093.
    PubMed     Text format    

  14. WALLERSTEDT A, Strom P, Gronberg H, Nordstrom T, et al
    Risk of Prostate Cancer in Men Treated With 5alpha-Reductase Inhibitors-A Large Population-Based Prospective Study.
    J Natl Cancer Inst. 2018 Mar 14. pii: 4935092. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Urol

  15. PATEL N, Hu JC
    Re: Recent Changes in Prostate Cancer Screening Practices and Epidemiology: D. J. Lee, K. Mallin, A. J. Graves, S. S. Chang, D. F. Penson, M. J. Resnick and D. A. Barocas J Urol 2017;198:1230-1240.
    J Urol. 2018 Mar 16. pii: S0022-5347(18)30117-4. doi: 10.1016/j.juro.2018.
    PubMed     Text format    


    Lancet Oncol

  16. GOURD E
    EMA guidance on radium-223 dichloride in prostate cancer.
    Lancet Oncol. 2018 Mar 15. pii: S1470-2045(18)30216.
    PubMed     Text format    


    N Engl J Med

  17. KASIVISVANATHAN V, Rannikko AS, Borghi M, Panebianco V, et al
    MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018 Mar 18. doi: 10.1056/NEJMoa1801993.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  18. THOMA C
    Prostate cancer: Radiosensitized by STAT5 blockade.
    Nat Rev Urol. 2018 Mar 20. pii: nrurol.2018.37. doi: 10.1038/nrurol.2018.
    PubMed     Text format    

  19. STONE L
    Prostate cancer: A novel mechanism of neuroendocrine transdifferentiation.
    Nat Rev Urol. 2018 Mar 20. pii: nrurol.2018.40. doi: 10.1038/nrurol.2018.
    PubMed     Text format    


    Oncogene

  20. JIA L, Wu D, Wang Y, You W, et al
    Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
    Oncogene. 2018 Mar 20. pii: 10.1038/s41388-018-0198.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  21. PATEL A, Fong L
    Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.
    Oncology (Williston Park). 2018;32:112-20.
    PubMed     Text format     Abstract available


    Prog Urol

  22. GEVORGYAN A, Hetet JF, Robert M, Duchattelle-Dussaule V, et al
    [Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results].
    Prog Urol. 2018 Mar 15. pii: S1166-7087(17)30543.
    PubMed     Text format     Abstract available


    Radiology

  23. LAWTON CAF
    Prostate Cancer: Improving the Flow of Research.
    Radiology. 2018;287:5-9.
    PubMed     Text format     Abstract available


    Urology

  24. BJURLIN MA, Turkbey B, Rosenkrantz AB, Gaur S, et al
    Imaging the High-Risk Prostate Cancer Patient: Current and Future Approaches to Staging.
    Urology. 2018 Mar 12. pii: S0090-4295(17)31305.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: